What it is
Thymulin is a hormone of nine amino acids made by the epithelial cells of the thymus. Its chain is pGlu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn — the first residue is pyroglutamate, a ring-closed form of glutamine (PubChem CID 71300623). It was first described in the 1970s by Jean-François Bach's group in Paris as the facteur thymique sérique (FTS, serum thymic factor), a substance in blood that helped immature T cells take on mature markers.
| Property | Value | Source |
|---|---|---|
| Sequence | pGlu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn | PubChem CID 71300623 |
| Length | 9 amino acids | — |
| Formula (zinc-free) | C33H54N12O15 | PubChem |
| Molecular weight | 858.9 | PubChem |
| Active form | One zinc atom per peptide (FTS-Zn) | PMID 6957870 |
Why zinc is the whole story
The name thymulin belongs to the zinc-bound form. In 1982, Dardenne and colleagues stripped metals from both natural and synthetic FTS with a chelating resin and found it lost its activity in their cell test; adding zinc back restored it, best at one zinc atom per peptide (PNAS, PMID 6957870). They proposed "thymulin" for the active FTS-Zn and confirmed the zinc by atomic absorption.
That dependency is why most human studies of thymulin are really studies of zinc. A 2021 rat study compared five ways of detecting marginal zinc deficiency: on the low-zinc diet, serum thymulin activity was 61% lower, against 31% for serum zinc and 18–28% for the other three markers (DiSilvestro et al., PMID 32363520). A 2014 Italian pilot measured thymulin activity in very old people who drank zinc-fortified milk for two months and reports a rise against ordinary milk (Costarelli et al., PMID 24771015). In both, thymulin is the measurement, not the treatment.
What the research in animals shows
A 2014 review from Dardenne and Goya's groups summarises the animal work: thymulin acts on the pituitary, and it and a synthetic analogue reduce inflammation and pain in rodent models; gene-therapy vectors carrying a thymulin analogue (metFTS) have been built and tested in mice without a thymus (Reggiani et al., PMID 24588820). Later mouse papers report the same anti-inflammatory direction in models of sepsis, type 1 diabetes, multiple sclerosis and asthma.
The largest recent study is a 2026 Nature Communications paper from the University of Southern California. It found more inflammatory myeloid cells — making IL-1α, IL-1β, IL-6 and TNF-α — in old mice and in older people. Using parabiosis (joining the circulation of young and old mice), it traced a young-blood factor that suppressed them to thymulin, which acted by blocking NF-κB signalling. Given to mice, thymulin improved tumour control and made tumours respond to anti-PD-L1 therapy in an age-dependent way (Kanemaru et al., PMID 42481458). One author reports an advisory role with Otsuka Pharmaceutical Factory. The human part of the study counted cells; nobody was given thymulin.
What is not established
- Any treatment effect in people. No registered trial gives thymulin to anyone. ClinicalTrials.gov's single result for the name is an infant zinc-supplementation study (NCT01229579, read 2026-11-19).
- That an injected dose would behave like the hormone. The active form needs zinc bound to it, and no study was found that tested a supplied peptide in a person.
- Anti-ageing or immune claims in people. No human study testing either was found.
A note on a confusing literature: "thymulin 5cH" in homeopathy papers is a homeopathic dilution of the hormone, studied in mice (PMID 25439044). It is not the peptide at a dose that could be measured.
Related entries: thymosin alpha-1, the 28-amino-acid thymus peptide approved as a drug in some countries · thymalin, a calf-thymus extract from the St Petersburg programme · thymogen · the family overview at thymosin · and the library's survey of peptides studied for immunity.
Where it stands
Thymulin is a natural hormone with a well-characterised chemistry, a large animal literature and one recent high-profile mouse study. In people it is a laboratory marker of zinc status. Questions about immunity or zinc belong to a doctor; this entry records what the compound is and what has been measured.
Sources opened 2026-11-19: PubChem (CID 71300623); PubMed E-utilities (counts; abstracts of PMIDs 6957870, 32363520, 24771015, 42481458, 24588820, 25439044); ClinicalTrials.gov API v2.
